volume 202 issue 7 pages 1051-1055

Five-Year Follow-up after Mesenchymal Stromal Cell–based Treatment of Severe Acute Respiratory Distress Syndrome

Oscar E Simonson 1, 2
Elisabeth Ståhle 1, 2
Tomas Hansen 1, 2
Johan O Wedin 1, 2
Anders Larsson 1, 2
Mattias Mattsson 1, 2
Katarina Le Blanc 4, 5
Sergey Rodin 2, 5
Karl-Henrik Grinnemo 1, 2, 5
Publication typeJournal Article
Publication date2020-10-01
scimago Q1
wos Q1
SJR5.076
CiteScore23.8
Impact factor19.4
ISSN1073449X, 15354970
Critical Care and Intensive Care Medicine
Pulmonary and Respiratory Medicine
Found 
Found 

Top-30

Journals

1
2
American Journal of Respiratory and Critical Care Medicine
2 publications, 20%
Frontiers in Molecular Biosciences
1 publication, 10%
npj Regenerative Medicine
1 publication, 10%
Cytotherapy
1 publication, 10%
EClinicalMedicine
1 publication, 10%
Problemy Endokrinologii
1 publication, 10%
Intensive Care Medicine Experimental
1 publication, 10%
Signal Transduction and Targeted Therapy
1 publication, 10%
1
2

Publishers

1
2
3
Springer Nature
3 publications, 30%
American Thoracic Society
2 publications, 20%
Elsevier
2 publications, 20%
Frontiers Media S.A.
1 publication, 10%
Endocrinology Research Centre
1 publication, 10%
Wiley
1 publication, 10%
1
2
3
  • We do not take into account publications without a DOI.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
10
Share
Cite this
GOST |
Cite this
GOST Copy
Simonson O. E. et al. Five-Year Follow-up after Mesenchymal Stromal Cell–based Treatment of Severe Acute Respiratory Distress Syndrome // American Journal of Respiratory and Critical Care Medicine. 2020. Vol. 202. No. 7. pp. 1051-1055.
GOST all authors (up to 50) Copy
Simonson O. E., Ståhle E., Hansen T., Wedin J. O., Larsson A., Mattsson M., Volchkov P., Le Blanc K., Rodin S., Grinnemo K. Five-Year Follow-up after Mesenchymal Stromal Cell–based Treatment of Severe Acute Respiratory Distress Syndrome // American Journal of Respiratory and Critical Care Medicine. 2020. Vol. 202. No. 7. pp. 1051-1055.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1164/rccm.202003-0544LE
UR - https://www.atsjournals.org/doi/10.1164/rccm.202003-0544LE
TI - Five-Year Follow-up after Mesenchymal Stromal Cell–based Treatment of Severe Acute Respiratory Distress Syndrome
T2 - American Journal of Respiratory and Critical Care Medicine
AU - Simonson, Oscar E
AU - Ståhle, Elisabeth
AU - Hansen, Tomas
AU - Wedin, Johan O
AU - Larsson, Anders
AU - Mattsson, Mattias
AU - Volchkov, Pavel
AU - Le Blanc, Katarina
AU - Rodin, Sergey
AU - Grinnemo, Karl-Henrik
PY - 2020
DA - 2020/10/01
PB - American Thoracic Society
SP - 1051-1055
IS - 7
VL - 202
PMID - 32501728
SN - 1073-449X
SN - 1535-4970
ER -
BibTex |
Cite this
BibTex (up to 50 authors) Copy
@article{2020_Simonson,
author = {Oscar E Simonson and Elisabeth Ståhle and Tomas Hansen and Johan O Wedin and Anders Larsson and Mattias Mattsson and Pavel Volchkov and Katarina Le Blanc and Sergey Rodin and Karl-Henrik Grinnemo},
title = {Five-Year Follow-up after Mesenchymal Stromal Cell–based Treatment of Severe Acute Respiratory Distress Syndrome},
journal = {American Journal of Respiratory and Critical Care Medicine},
year = {2020},
volume = {202},
publisher = {American Thoracic Society},
month = {oct},
url = {https://www.atsjournals.org/doi/10.1164/rccm.202003-0544LE},
number = {7},
pages = {1051--1055},
doi = {10.1164/rccm.202003-0544LE}
}
MLA
Cite this
MLA Copy
Simonson, Oscar E., et al. “Five-Year Follow-up after Mesenchymal Stromal Cell–based Treatment of Severe Acute Respiratory Distress Syndrome.” American Journal of Respiratory and Critical Care Medicine, vol. 202, no. 7, Oct. 2020, pp. 1051-1055. https://www.atsjournals.org/doi/10.1164/rccm.202003-0544LE.